World In Vitro Diagnostics - Market Opportunities and Forecasts, 2015 - 2022

Table of Contents

CHAPTER 1 INTRODUCTION

1.1 Report description

1.2 Key benefits

1.3 Key market segments

1.4 Research methodology

1.4.1 Secondary research

1.4.2 Primary research

1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective

2.2 Market beyond: what to expect by 2027

2.2.1 Base case scenario

2.2.2 Rapid growth scenario

2.2.3 Diminishing growth scenario

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope

3.2 Key findings

3.2.1 Top impacting factors

3.2.2 Top investment pockets

3.2.3 Top winning strategies

3.3 Porter five forces analysis

3.3.1 Bargaining power of supplier

3.3.2 Bargaining power of buyers

3.3.3 Low threat of new entrants

3.3.4 Threat of substitute

3.3.5 Competitive rivalry

3.4 Government regulations

3.5 Value chain analysis

3.6 Case studies

3.6.1 Case Study 1: Positioning of new IVD Platform by Life Science

3.6.2 Case Study 2: To enhance the operational capabilities of diagnostic chemistry system

3.7 Research & Analysis

3.7.1 Clinical Trials of research studies conducted for IVD market

3.8 Significant Progressions in IVD technologies

3.8.1 Total Laboratory Automation (TLA)

3.8.2 Evolving markets in digital pathology

3.8.3 Omics and Genetics tests in IVD

3.8.4 Point-of-Care testing

3.8.5 Emerging technologies diagnostics and influence on IVD

3.9 Market dynamics

3.9.1 Drivers

3.9.1.1 Increasing incidences of chronic and infectious diseases

3.9.1.2 Technological advancements in IVD

3.9.1.3 Emergence of minimal invasive technologies

3.9.1.4 Increasing government expenditures on healthcare

3.9.1.5 Increase in popularity personalized medicine approach

3.9.2 Restraints

3.9.2.1 Unclear reimbursement policies

3.9.2.2 Stringent Regulatory policies

3.9.3 Opportunities

3.9.3.1 Potential Opportunities for outsourcing

3.9.3.2 Convergence of new Technologies.

CHAPTER 4 WORLD IVD MARKET, BY PRODUCT TYPE, 2014-2022

4.1 Overview

4.1.1 Market size and forecast

4.2 Reagents

4.2.1 Key market trends

4.2.2 Key growth factors and opportunities

4.2.3 Market size and forecast

4.3 Instruments

4.3.1 Key market trends

4.3.2 Key growth factors and opportunities

4.3.3 Market size and forecast

4.4 Software and services

4.4.1 Key market trends

4.4.2 Key growth factors and opportunities

4.4.3 Market size and forecast

CHAPTER 5 WORLD IVD MARKET, BY TECHNIQUES, 2014-2022

5.1 Immunodiagnostics

5.1.1 Key market trends

5.1.2 Key growth factors and opportunities

5.1.3 Market size and forecast

5.2 Blood testing

5.2.1 Key market trends

5.2.2 Key growth factors and opportunities

5.2.3 Market size and forecast

5.3 Molecular diagnostics

5.3.1 Key market trends

5.3.2 Key growth factors and opportunities

5.3.3 Market size and forecast

5.4 Tissue diagnostics

5.4.1 Key market trends

5.4.2 Key growth factors and opportunities

5.4.3 Market size and forecast

5.5 Clinical chemistry

5.5.1 Key market trends

5.5.2 Key growth factors and opportunities

5.5.3 Market size and forecast

5.6 Other clinical techniques

5.6.1 Key market trends

5.6.2 Key growth factors and opportunities

5.6.3 Market size and forecast

CHAPTER 6 WORLD IVD MARKET, BY APPLICATION, 2014-2022

6.1 Infectious diseases

6.1.1 Key market trends

6.1.2 Key growth factors and opportunities

6.1.3 Market size and forecast

6.2 Cancer

6.2.1 Key market trends

6.2.2 Key growth factors and opportunities

6.2.3 Market size and forecast

6.3 Cardiac diseases

6.3.1 Key market trends

6.3.2 Key growth factors and opportunities

6.3.3 Market size and forecast

6.4 Immune system diseases

6.4.1 Key market trends

6.4.2 Key growth factors and opportunities

6.4.3 Market size and forecast

6.5 Nephrological diseases

6.5.1 Key market trends

6.5.2 Key growth factors and opportunities

6.5.3 Market size and forecast

6.6 Gastrointestinal diseases

6.6.1 Key market trends

6.6.2 Key growth factors and opportunities

6.6.3 Market size and forecast

6.7 Other indications

6.7.1 Key market trends

6.7.2Key growth factors and opportunities

6.7.3Market size and forecast

CHAPTER 7 WORLD IVD MARKET BY END USERS, 2014-2022

7.1 Standalone laboratories

7.1.1 Market size and forecast

7.2 Hospitals

7.2.1 Key market trends

7.2.2 Key growth factors and opportunities

7.2.3 Market size and forecast

7.3 Academic and medical schools

7.3.1 Key market trends

7.3.2 Key growth factors and opportunities

7.3.3 Market size and forecast

7.4 Others

7.4.1 Key market trends

7.4.2 Key growth factors and opportunities

7.4.3 Market size and forecast

CHAPTER 8 WORLD IVD MARKET BY GEOGRAPHY, 2014-2022

8.1 North America

8.1.1 Key market trends

8.1.2 Key growth factors and opportunities

8.1.3 Market size and forecast

8.1.4 United states

8.1.4.1 Market size and forecast

8.1.5 Canada

8.1.5.1 Market size and forecast

8.1.6 Mexico

8.1.6.1 Market size and forecast

8.2 Europe

8.2.1 Key market trends

8.2.2 Key growth factors and opportunities

8.2.3 Market size and forecast

8.2.4 Germany

8.2.4.1 Market size and forecast

8.2.5 France

8.2.5.1 Market size and forecast

8.2.6 United Kingdom

8.2.6.1 Market size and forecast

8.2.7 Others

8.2.7.1 Market size and forecast

8.3 Asia Pacific

8.3.1 Key market trends

8.3.2 Key growth factors and opportunities

8.3.3 Market size and forecast

8.3.4 India

8.3.4.1 Market size and forecast

8.3.5 China

8.3.5.1 Market size and forecast

8.3.6 Japan

8.3.6.1 Market size and forecast

8.3.7 Australia

8.3.7.1 Market size and forecast

8.3.8 Others

8.3.8.1 Market size and forecast

8.4 LAMEA

8.4.1 Key market trends

8.4.2 Key growth factors and opportunities

8.4.3 Market size and forecast

8.4.4 Latin America

8.4.4.1 Market size and forecast

8.4.5 Middle East

8.4.5.1 Market size and forecast

8.4.6 Africa

8.4.6.1 Market size and forecast

CHAPTER 9 COMPANY PROFILES

9.1 Affymetrix Inc.

9.1.1 Company overview

9.1.2 Company snapshot

9.1.3 Financial performance of Affymetrix Inc.

9.1.4 Key Strategies and development

9.1.5 SWOT analysis of Affymetrix

9.2 Alere Inc.

9.2.1 Company overview

9.2.2 Company snapshot

9.2.3 Business performance

9.2.4 Key strategies and developments

9.2.5 SWOT analysis of Alere

9.3 Biomerieux

9.3.1 Company overview

9.3.2 Company snapshot

9.3.3 Business performance

9.3.4 Key strategies and developments

9.3.5 SWOT analysis of BioMerieux

9.4 Danaher Corporation.

9.4.1 Company overview

9.4.2 Company snapshot

9.4.3 Business performance

9.4.4 Key strategies and development

9.4.5 SWOT analysis of Danaher Corporation

9.5 Roche Diagnostics

9.5.1 Company overview

9.5.2 Company snapshot

9.5.3 Business performance

9.5.4 Key strategies and developments

9.5.5 SWOT analysis of Roche Diagnostics

9.6 Becton Dickinson and Company

9.6.1 Company overview

9.6.2 Company snapshot

9.6.3 Business performance

9.6.4 Key strategies and development

9.6.5 SWOT analysis of Becton Dickinson and Company

9.7 Bio-Rad Laboratories, Inc.

9.7.1 Company overview

9.7.2 Company snapshot

9.7.3 Business performance

9.7.4 Key strategies and developments

9.7.5 SWOT analysis of Bio-Rad Laboratories, Inc.

9.8 Abbott Laboratories

9.8.1 Company overview

9.8.2 Company snapshot

9.8.3 Business performance

9.8.4 Key strategies and developments

9.8.5 SWOT analysis of Abbott Laboratories

9.9 Bayer AG.

9.9.1 Company overview

9.9.2 Company snapshot

9.9.3 Business performance

9.9.4 Key strategies and development

9.9.5 SWOT analysis of Bayer AG

9.10 Arkray, Inc.

9.10.1 Company overview

9.10.2 Company snapshot

9.10.3 Key strategies and development

9.10.4 SWOT analysis of Arkray, Inc.

9.11 Sysmex Corporation

9.11.1 Company overview

9.11.2 Company snapshot

9.11.3 Business performance

9.11.4 Key strategies and developments

9.11.5 SWOT analysis of Sysmex Corporation

9.12 Johnson & Johnson Pvt Ltd.

9.12.1 Company overview

9.12.2 Company snapshot

9.12.3 Business performance

9.12.4 Key strategies and development

9.12.5 SWOT analysis of Johnson & Johnson Pvt Ltd.

9.13 Siemens AG

9.13.1 Company overview

9.13.2 Company snapshot

9.13.3 Business performance

9.13.4 Key strategies and development

9.13.5 SWOT analysis of Siemens AG

List of Figures

FIG. 1 WORLD IVD MARKET SNAPSHOT

FIG. 1 TOP IMPACTING FACTORS, BASE CASE SCENARIO (2022-2027)

FIG. 2 TOP IMPACTING FACTORS, RAPID GROWTH SCENARIO (2022-2027)

FIG. 3 TOP IMPACTING FACTORS, DIMINISHING GROWTH SCENARIO (2022-2027)

FIG. 4 TOP IMPACTING FACTORS

FIG. 5 TOP INVESTMENT POCKETS OF IVD MARKET BY TECHNIQUES 2014-2022.

FIG. 6 TOP WINNING STRATEGIES

FIG. 7 TOP WINNING STRATEGIES

FIG. 8 VALUE CHAIN ANALYSIS FOR IVD MARKET

FIG. 9 KEY FINANCIALS OF AFFYMETRIX INC. REVENUE, 2012-2014, $MILLION

FIG. 10 KEY FINANCIALS OF AFFYMETRIX INC. REVENUE BY SEGMENTS

FIG. 11 KEY FINANCIALS OF AFFYMETRIX INC.CORPORATION REVENUE BY GEOGRAPHY

FIG. 12 SWOT ANALYSIS OF AFFYMETRIX INC.

FIG. 13 KEY FINANCIALS OF ALERE INC. REVENUE, 2012-2014, $MILLION

FIG. 14 ALERE INC., % NET SALES BY BUSINESS SEGMENTS, 2014

FIG. 15 ALERE INC., % NET SALES BY GEOGRAPHY, 2014

FIG. 16 SWOT ANALYSIS OF ALERE INC.

FIG. 17 KEY FINANCIALS OF BIOMERIEUX REVENUE, 2011-2014, $MILLION

FIG. 18 BIOMERIEUX, % NET SALES BY TECHNOLOGY, 2014

FIG. 19 BIOMERIEUX, % NET SALES BY GEOGRAPHY, 2014

FIG. 20 SWOT ANALYSIS OF BIOMERIEUX

FIG. 21 DANAHER CORPORATION, % NET SALES BY BUSINESS SEGMENT, 2014

FIG. 22 DANAHER CORPORATION, % NET SALES BY GEOGRAPHY, 2014

FIG. 23 SWOT ANALYSIS OF DANAHER CORPORATION

FIG. 24 KEY FINANCIALS OF ROCHE DIAGNOSTICS REVENUE, 2012-2014, $MILLION

FIG. 25 ROCHE DIAGNOSTICS, % NET SALES BY BUSINESS SEGMENT, 2014

FIG. 26 ROCHE DIAGNOSTICS, % NET SALES BY GEOGRAPHY, 2014

FIG. 27 SWOT ANALYSIS OF ROCHE DIAGNOSTICS

FIG. 28 KEY FINANCIALS OF BECTON, DICKINSON AND COMPANY REVENUE, 2011-2014, $MILLION

FIG. 29 KEY FINANCIALS OF BECTON DICKINSON AND COMPANY REVENUES BY SEGMENT 2014

FIG. 30 KEY FINANCIALS OF BECTON DICKINSON AND COMPANY SALES BY GEOGRAPHY 2014

FIG. 31 SWOT ANALYSIS OF BECTON DICKINSON AND COMPANY

FIG. 32 KEY FINANCIALS OF BIO-RAD LABORATORIES REVENUE, 2012-2014, $MILLION

FIG. 33 BIO RAD LABORATORIES, INC., % REVENUE BY BUSINESS SEGMENT, 2014

FIG. 34 BIO RAD LABORATORIES, INC., % REVENUE BY GEOGRAPHY, 2014

FIG. 35 SWOT ANALYSIS OF BIO-RAD LABORATORIES, INC.

FIG. 36 KEY FINANCIALS OF ABBOTT LABORATORIES REVENUE, 2012-2014, $MILLION

FIG. 37 ABBOTT LABORATORIES, INC., % REVENUE BY BUSINESS SEGMENT, 2014

FIG. 38 ABBOTT LABORATORIES, INC., % REVENUE BY GEOGRAPHY, 2014

FIG. 39 SWOT ANALYSIS OF ABBOTT LABORATORIES

FIG. 40 KEY FINANCIALS OF ABBOTT LABORATORIES REVENUE, 2012-2014, $MILLION

FIG. 41 BAYER AG, % REVENUE BY BUSINESS SEGMENT, 2014

FIG. 42 SWOT ANALYSIS OF BAYER AG

FIG. 43 SWOT ANALYSIS OF ARKRAY, INC.

FIG. 44 KEY FINANCIALS OF SYSMEX CORPORATION REVENUE, 2012-2014, $MILLION

FIG. 45 SYSMEX CORPORATION, % REVENUE, BY BUSINESS SEGMENT, 2014

FIG. 46 SYSMEX CORPORATION, % REVENUE, BY PRODUCT TYPE, 2014

FIG. 47 SYSMEX CORPORATION, % REVENUE BY GEOGRAPHY, (2014)

FIG. 48 SWOT ANALYSIS OF SYSMEX CORPORATION

FIG. 49 KEY FINANCIALS OF JOHNSON & JOHSNON $MILLION (2012-2014)

FIG. 50 FINANCIAL REVENUES BY SEGMENTS (2014)

FIG. 51 FINANCIAL REVENUES BY GEOGRAPHY (2014)

FIG. 52 SWOT ANALYSIS OF JOHNSON & JOHNSON PVT LTD.

FIG. 53

FIG. 54 SIEMENS AG., % REVENUE BY BUSINESS SEGMENT, 2014

FIG. 55 SIEMENS AG., % REVENUE BY GEOGRAPHY, 2014

FIG. 56 SWOT ANALYSIS OF SIEMENS AG

List of Table

TABLE 1 WORLD IVD BASE CASE SCENARIO MARKET, BY GEOGRAPHY, 2022 2027 ($MILLION)

TABLE 2 WORLD IVD RAPID GROWTH SCENARIO MARKET, BY GEOGRAPHY, 2022 2027 ($MILLION)

TABLE 3 WORLD IVD DIMINISHING GROWTH SCENARIO MARKET, BY GEOGRAPHY, 2022 2027 ($MILLION)

TABLE 4 PORTERS FIVE FORCES ANALYSIS

TABLE 5 CLINICAL TRIALS - IN VITRO DIAGNOSTIC DEVICES

TABLE 6 GLOBAL INCIDENCES OF DISEASES

TABLE 7 WORLD IVD MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)

TABLE 8 WORLD IVD REAGENTS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 9 WORLD IVD INSTRUMENTS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 10 WORLD IVD SOFTWARE AND SERVICES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 11 WORLD IVD MARKET BY TECHNIQUE, 2014-2022 ($MILLION)

TABLE 12 WORLD IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 13 WORLD IVD BLOOD TESTING TECHNIQUE MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 14 WORLD IVD MOLECULAR DIAGNOSTICS TECHNIQUE MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 15 WORLD IVD TISSUE DIAGNOSTICS TECHNIQUE MARKET, 2014-2022, ($MILLION)

TABLE 16 WORLD IVD CLINICAL CHEMISTRY TECHNIQUE MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 17 WORLD IVD OTHER CLINICAL TECHNIQUES MARKET, BY GEOGRAPHY, 2014-2022, ($MILLION)

TABLE 18 WORLD IVD MARKET, BY INDICATION, 2014-2022 ($MILLION)

TABLE 19 WORLD IVD INFECTIOUS DISEASES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 20 WORLD IVD CANCER MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 21 WORLD IVD CARDIAC DISEASES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 22 WORLD IVD IMMUNE SYSTEM DISORDER MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 23 WORLD IVD NEPHROLOGICAL DISEASES MARKET, BY GEOGRAPHY, 2014-2022, ($MILLION)

TABLE 24 WORLD IVD GASTRINTESTINAL DISEASES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 25 WORLD IVD OTHER INDICATION MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 26 WORLD IVD MARKET, BY END USER, 2014-2022, ($MILLION)

TABLE 27 WORLD IVD STANDALONE LABORATORIES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 28 WORLD IVD HOSPITALS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 29 WORLD IVD ACADEMIC AND MEDICAL SCHOOLS MARKET, BY GEOGRAPHY, 2014- 2022 ($MILLION)

TABLE 30 WORLD IVD OTHERS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 31 WORLD IVD MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 32 NORTH AMERICA IVD MARKET, BY TECHNIQUES, 2014-2022 ($MILLION)

TABLE 33 UNITED STATES IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)

TABLE 34 CANADA IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)

TABLE 35 MEXICO IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)

TABLE 36 EUROPE IVD MARKET, BY TECHNIQUES, 2014-2022 ($MILLION)

TABLE 37 GERMANY IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)

TABLE 38 FRANCE IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)

TABLE 39 UNITED KINGDOM IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)

TABLE 40 OTHERS EUROPEAN IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)

TABLE 41 ASIA PACIFIC IVD MARKET, BY TECHNIQUES, 2014-2022 ($MILLION)

TABLE 42 INDIA IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)

TABLE 43 CHINA IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)

TABLE 44 JAPAN IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)

TABLE 45 CATEGORIZATION OF IVD DEVICES

TABLE 46 AUSTRALIA IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)

TABLE 47 OTHERS IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)

TABLE 48 LAMEA IVD MARKET, BY TECHNIQUES, 2014-2022 ($MILLION)

TABLE 49 LATIN AMERICA IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)

TABLE 50 MIDDLE EAST IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)

TABLE 51 AFRICA IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)

TABLE 52 COMPANY SNAPSHOT OF AFFYMETRIX INC.

TABLE 53 ALERE INC. COMPANY SNAPSHOT

TABLE 54 BIOMERIEUX COMPANY SNAPSHOT

TABLE 55 DANAHER CORPORATION COMPANY SNAPSHOT

TABLE 56 ROCHE DIAGNOSTICS COMPANY SNAPSHOT

TABLE 57 BECTON DICKINSON AND COMPANY SNAPSHOT

TABLE 58 BIO-RAD LABORATORIES, INC. COMAPNY SNAPSHOT

TABLE 59 ABBOTT LABORATORIES SNAPSHOT

TABLE 60 BAYER AG COMPANY SNAPSHOT

TABLE 61 ARKRAY, INC. COMPANY SNAPSHOT

TABLE 62 SYSMEX CORPORATION COMPANY SNAPSHOT

TABLE 63 JOHNSON & JOHNSON PVT LTD. COMPANY SNAPSHOT

TABLE 64 SIEMENS AGCOMPANY SNAPSHOT